Real-World (RW) treatment patterns in patients with T2DM newly initiated with antihyperglycemic (AHA) medications in the US

被引：0

作者：

Cai, Jennifer ^{[1
]}

Burudpakdee, Chakkarin ^{[2
]}

Divino, Victoria ^{[2
]}

Fegade, Mayuresh ^{[3
]}

机构：

[1] Janssen, Beerse, Belgium

[2] IMS Hlth, Danbury, CT USA

[3] Janssen Med Affairs, Bombay, Maharashtra, India

来源：

DIABETES RESEARCH AND CLINICAL PRACTICE | 2016年 / 120卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PD-82

引用

页码：S117 / S117

页数：1

共 50 条

[31] Real-World 12-Month Outcomes of Patients with Type 2 Diabetes Mellitus (T2DM) Treated with Canagliflozin in a US Managed Care Setting
Chow, Wing
Buysman, Erin K.
Rupnow, Marcia F. T.
Anderson, Amy J.
Henk, Henry J.
DIABETES, 2016, 65 : A321 - A321
[32] Unmet Needs and Treatment Patterns of T2DM Patients with Basal Insulin
Dalal, Mehul
Grabner, Michael
Gidaya, Nicole
Bieszk, Nella
Digenio, Andres
DIABETES, 2014, 63 : A232 - A232
[33] Real-world treatment patterns among newly diagnosed myelofibrosis patients.
Yang, Yoojung
Lu, Mei
Hooper, Ellen
Feliciano, Joseph
Aly, Abdalla
Mesa, Ruben A.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[34] REAL-WORLD ADHERENCE IN MEDICARE PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) FOR EXENATIDE QW AND LIRAGLUTIDE QD
Tarr, A.
Nguyen, H.
Dufour, R.
Bullano, M.
VALUE IN HEALTH, 2015, 18 (03) : A57 - A57
[35] Association of Treatment Persistence and Adherence With Real-World Outcomes Among Insulin-Treated Patients With Type 2 Diabetes Mellitus (T2DM)
Wei, Wenhui
Pan, Chunshen
Xie, Lin
Baser, Onur
DIABETES, 2012, 61 : A4 - A4
[36] Real-World A1C Changes and Prescribing Provider Types among T2DM Patients Initiating Treatment with Oral Semaglutide
Frazer, Monica S.
Swift, Caroline
Leszko, Michael
Sargent, Andrew
Buysman, Erin
Alvarez, Sara B.
Noone, Joshua
Guevarra, Mico
DIABETES, 2022, 71
[37] Real-World Treatment Patterns for Golimumab and Concomitant Medications in Japanese Rheumatoid Arthritis Patients
Masateru Okazaki
Hisanori Kobayashi
Yutaka Ishii
Masayoshi Kanbori
Tsutomu Yajima
Rheumatology and Therapy, 2018, 5 : 185 - 201
[38] Real-World Impact of HbA1c Reduction on Treatment Intensification and HbA1c Goal Attainment in T2DM Patients Initiated on SGLT2i
Brunton, Stephen
Rozjabek, Heather M.
Pilon, Dominic
Lafeuille, Marie-Helene
Kamstra, Rhiannon L.
Wynant, Willy
Bookhart, Brahim
Lefebvre, Patrick
DIABETES, 2018, 67
[39] Real-World Treatment Patterns for Golimumab and Concomitant Medications in Japanese Rheumatoid Arthritis Patients
Okazaki, Masateru
Kobayashi, Hisanori
Ishii, Yutaka
Kanbori, Masayoshi
Yajima, Tsutomu
RHEUMATOLOGY AND THERAPY, 2018, 5 (01) : 185 - 201
[40] The Impact of Hypoglycemia on Health Care Use and Costs in T2DM Patients Newly Initiated on Basal Insulin
Dalal, Mehul R.
Kazemi, Mahmood
Ye, Fen
Xie, Lin
DIABETES, 2015, 64 : A351 - A351

← 1 2 3 4 5 →